Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohan Suryo Rahmanto

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Biochimica Et Biophysica Acta|February 28, 2009
Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): no overt alteration in phenotypeYohan Suryo Rahmanto, Des R Richardson
The Biochemical Journal|February 16, 2007
Differential regulation of the Menkes and Wilson disease copper transporters by hormones: an integrated model of metal transport in the placentaDes R Richardson, Yohan Suryo Rahmanto
Biochimica Et Biophysica Acta|July 22, 2010
The translational regulator eIF3a: the tricky eIF3 subunit!Federica Saletta, Yohan Suryo Rahmanto, Des R Richardson
Trends in Cell Biology|December 30, 2006
Iron uptake and metabolism in the new millenniumLouise L Dunn, Yohan Suryo Rahmanto, Des R Richardson
Molecular Pharmacology|December 22, 2009
Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53Federica Saletta, Yohan Suryo Rahmanto, Egarit Noulsri, et al.
Molecular Pharmacology|March 11, 2011
The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activityYu Yu, Yohan Suryo Rahmanto, Clare L Hawkins, et al.
The Journal of Biological Chemistry|August 20, 2011
Cellular iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genesFederica Saletta, Yohan Suryo Rahmanto, Aritee R Siafakas, et al.
Blood|November 18, 2005
Role of melanotransferrin in iron metabolism: studies using targeted gene disruption in vivoEric O Sekyere, Louise L Dunn, Yohan Suryo Rahmanto, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2005
Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediatesNeil P Davies, Yohan Suryo Rahmanto, Christopher R Chitambar, et al.
Biochimica Et Biophysica Acta|September 22, 2011
Melanotransferrin: search for a functionYohan Suryo Rahmanto, Sumeet Bal, Kim H Loh, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Biochimica Et Biophysica Acta|February 28, 2009
Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): no overt alteration in phenotypeYohan Suryo Rahmanto, Des R Richardson
The Biochemical Journal|February 16, 2007
Differential regulation of the Menkes and Wilson disease copper transporters by hormones: an integrated model of metal transport in the placentaDes R Richardson, Yohan Suryo Rahmanto
Biochimica Et Biophysica Acta|July 22, 2010
The translational regulator eIF3a: the tricky eIF3 subunit!Federica Saletta, Yohan Suryo Rahmanto, Des R Richardson
Trends in Cell Biology|December 30, 2006
Iron uptake and metabolism in the new millenniumLouise L Dunn, Yohan Suryo Rahmanto, Des R Richardson
Molecular Pharmacology|December 22, 2009
Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53Federica Saletta, Yohan Suryo Rahmanto, Egarit Noulsri, et al.
Molecular Pharmacology|March 11, 2011
The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activityYu Yu, Yohan Suryo Rahmanto, Clare L Hawkins, et al.
The Journal of Biological Chemistry|August 20, 2011
Cellular iron depletion and the mechanisms involved in the iron-dependent regulation of the growth arrest and DNA damage family of genesFederica Saletta, Yohan Suryo Rahmanto, Aritee R Siafakas, et al.
Blood|November 18, 2005
Role of melanotransferrin in iron metabolism: studies using targeted gene disruption in vivoEric O Sekyere, Louise L Dunn, Yohan Suryo Rahmanto, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2005
Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediatesNeil P Davies, Yohan Suryo Rahmanto, Christopher R Chitambar, et al.
Biochimica Et Biophysica Acta|September 22, 2011
Melanotransferrin: search for a functionYohan Suryo Rahmanto, Sumeet Bal, Kim H Loh, et al.
Pageof 5